ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.91 Cr | ₹9.31 Cr | ₹5.36 Cr | ₹5.43 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹7.91 Cr |
| Mar2025 | ₹9.31 Cr |
| Mar2024 | ₹5.36 Cr |
| Mar2023 | ₹5.43 Cr |
| Mar2022 | ₹13 Cr |
How is Contingent Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.91 Cr | -14.97 | |
| Mar2025 | ₹9.31 Cr | 73.70 | |
| Mar2024 | ₹5.36 Cr | -1.40 | |
| Mar2023 | ₹5.43 Cr | -58.47 | |
| Mar2022 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,088.5 Cr | 8.6% | 0.4% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 8.6% |
0.4% |
-12.9% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses